“We have come to know that the COVID-19 vaccination campaign is being carried out by the hospital today. Kovaxin manufactured by Bharat Biotech is being preferred over Covishield manufactured by the Serum Institute in our hospital.

“Residents are a little apprehensive about the lack of complete testing in the case of kovaxine and cannot participate in large numbers, thus defeating the purpose of vaccination. We request you to vaccinate us with Kovild who has Has completed all stages of testing before its roll. Outside, “the letter said.

Prime Minister Narendra Modi on Saturday launched India’s COVID-19 vaccination campaign and said the vaccine being prepared in India would ensure a “decisive victory” for the country over the coronavirus epidemic.

In the national capital, the vaccination exercise will be carried out at 81 locations in all its 11 districts.

At RML Hospital, a security guard was the first to receive the shot.

Six central government hospitals – AIIMS, Safdarjung, RML, Kalavati Saran Children’s Hospital and two ESI hospitals have been selected as sites for the drive.

Apart from these, Lok Nayak Jai Prakash Narayan Hospital, Delhi Government run GTB Hospital, Rajiv Gandhi Super Specialty Hospital, DDU Hospital, BSA Hospital, Delhi State Cancer Institute, ILBS Hospital are among the vaccination sites.

Private facilities – Max Hospital, Fortis Hospital, Apollo Hospital and Sir Ganga Ram Hospital have also been selected as sites for practice.

According to the government, the shots will be offered to an estimated one crore healthcare workers and about two crore frontline workers, and then to individuals over 50 years of age, followed by those under 50 years of age with comradities.

The cost of vaccination for healthcare and frontline workers will be borne by the central government.